1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 PSA Tests
1.2.3 CTC Tests
1.2.4 Immunohistochemistry
1.2.5 PCA3 Tests
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Testing Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospital Associated Labs
1.3.3 Independent Diagnostic Laboratories
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Testing Market Perspective (2018-2030)
2.2 Prostate Cancer Testing Growth Trends by Region
2.2.1 Prostate Cancer Testing Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Prostate Cancer Testing Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Testing Forecasted Market Size by Region (2023-2030)
2.3 Prostate Cancer Testing Market Dynamics
2.3.1 Prostate Cancer Testing Industry Trends
2.3.2 Prostate Cancer Testing Market Drivers
2.3.3 Prostate Cancer Testing Market Challenges
2.3.4 Prostate Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Testing Players by Revenue
3.1.1 Global Top Prostate Cancer Testing Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Testing Revenue
3.4 Global Prostate Cancer Testing Market Concentration Ratio
3.4.1 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Testing Revenue in 2022
3.5 Prostate Cancer Testing Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Testing Product Solution and Service
3.7 Date of Enter into Prostate Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Testing Breakdown Data by Type
4.1 Global Prostate Cancer Testing Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2023-2030)
5 Prostate Cancer Testing Breakdown Data by Application
5.1 Global Prostate Cancer Testing Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Prostate Cancer Testing Market Size (2018-2030)
6.2 North America Prostate Cancer Testing Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Testing Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Testing Market Size (2018-2030)
7.2 Europe Prostate Cancer Testing Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Testing Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Testing Market Size (2018-2030)
8.2 Asia-Pacific Prostate Cancer Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Testing Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Testing Market Size (2018-2030)
9.2 Latin America Prostate Cancer Testing Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Testing Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Testing Market Size (2018-2030)
10.2 Middle East & Africa Prostate Cancer Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Testing Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Genomic Health
11.1.1 Genomic Health Company Detail
11.1.2 Genomic Health Business Overview
11.1.3 Genomic Health Prostate Cancer Testing Introduction
11.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2018-2023)
11.1.5 Genomic Health Recent Development
11.2 OPKO
11.2.1 OPKO Company Detail
11.2.2 OPKO Business Overview
11.2.3 OPKO Prostate Cancer Testing Introduction
11.2.4 OPKO Revenue in Prostate Cancer Testing Business (2018-2023)
11.2.5 OPKO Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Detail
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Prostate Cancer Testing Introduction
11.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2018-2023)
11.3.5 Siemens Healthcare Recent Development
11.4 DiaSorin
11.4.1 DiaSorin Company Detail
11.4.2 DiaSorin Business Overview
11.4.3 DiaSorin Prostate Cancer Testing Introduction
11.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2018-2023)
11.4.5 DiaSorin Recent Development
11.5 bioMeriux
11.5.1 bioMeriux Company Detail
11.5.2 bioMeriux Business Overview
11.5.3 bioMeriux Prostate Cancer Testing Introduction
11.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2018-2023)
11.5.5 bioMeriux Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Prostate Cancer Testing Introduction
11.6.4 Roche Revenue in Prostate Cancer Testing Business (2018-2023)
11.6.5 Roche Recent Development
11.7 MDx Health
11.7.1 MDx Health Company Detail
11.7.2 MDx Health Business Overview
11.7.3 MDx Health Prostate Cancer Testing Introduction
11.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2018-2023)
11.7.5 MDx Health Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Detail
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Prostate Cancer Testing Introduction
11.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2018-2023)
11.8.5 Beckman Coulter Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Detail
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Prostate Cancer Testing Introduction
11.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2018-2023)
11.9.5 Myriad Genetics Recent Development
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Detail
11.10.2 Ambry Genetics Business Overview
11.10.3 Ambry Genetics Prostate Cancer Testing Introduction
11.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2018-2023)
11.10.5 Ambry Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
